Navigating the Landscape of Molecular Testing and Treatments With Targeted Therapies for Patients With Non-Small Cell Lung Cancer
Phoenix, AZ US
November 7, 2015
Learning Objectives
- Discuss evidence-based guidelines for the biopsy, histology, and molecular testing for diagnostic/prognostic markers
- Describe scientific updates and key practice changes in the management of lung cancer, focusing on targeted treatments and including both new and investigational biologic therapies
- Identify the common disease symptoms and/or side effects encountered in the management of non-small cell lung cancer and detail the best management strategies utilized by advanced practitioners (APs) in oncology
- Describe collaboration between various members of the healthcare team (including but not limited to physician, AP, and pharmacist) in the care of NSCLC
JW Marriott Desert Ridge
5350 East Marriott Drive
Phoenix, AZ
85054
United States
Donald Harvey, PharmD, FCCP, BCOP
Sukhmani Padda, MD
Available Credit
- 1.00 AANP
- 0.67 Pharmacology
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance
- 1.00 ANCC